BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25953673)

  • 21. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion.
    Wang L; Wu Y; Lin L; Liu P; Huang H; Liao W; Zheng D; Zuo Q; Sun L; Huang N; Shi M; Liao Y; Liao W
    Int J Cancer; 2013 Sep; 133(6):1419-30. PubMed ID: 23457029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy.
    Kawamura M; Saigusa S; Toiyama Y; Tanaka K; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Anticancer Res; 2012 Apr; 32(4):1527-31. PubMed ID: 22493396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
    Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
    Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of neutrophil distribution in cholangiocarcinoma.
    Mao ZY; Zhu GQ; Xiong M; Ren L; Bai L
    World J Gastroenterol; 2015 Apr; 21(16):4961-8. PubMed ID: 25945010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma.
    Qiu J; Huang P; Liu Q; Hong J; Li B; Lu C; Wang L; Wang J; Yuan Y
    J Transl Med; 2011 Sep; 9():166. PubMed ID: 21955323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection.
    Groot Koerkamp B; Wiggers JK; Allen PJ; Besselink MG; Blumgart LH; Busch OR; Coelen RJ; D'Angelica MI; DeMatteo RP; Gouma DJ; Kingham TP; Jarnagin WR; van Gulik TM
    J Am Coll Surg; 2015 Dec; 221(6):1041-9. PubMed ID: 26454735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis.
    Stein U; Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Schlag PM
    PLoS One; 2012; 7(11):e49249. PubMed ID: 23166620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.
    Yu Y; Chen Y; Ma J; Yu X; Yu G; Li Z
    Tumour Biol; 2016 Mar; 37(3):4159-67. PubMed ID: 26490986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma.
    Thelen A; Scholz A; Weichert W; Wiedenmann B; Neuhaus P; Gessner R; Benckert C; Jonas S
    Am J Gastroenterol; 2010 May; 105(5):1123-32. PubMed ID: 19997097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.
    Sun Q; Li F; Sun F; Niu J
    Int J Clin Exp Pathol; 2015; 8(7):8376-84. PubMed ID: 26339407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma.
    Li HF; Liu YQ; Shen ZJ; Gan XF; Han JJ; Liu YY; Li HG; Huang ZQ
    Oncol Rep; 2015 Feb; 33(2):651-60. PubMed ID: 25421538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
    Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
    Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations.
    Galimi F; Torti D; Sassi F; Isella C; Corà D; Gastaldi S; Ribero D; Muratore A; Massucco P; Siatis D; Paraluppi G; Gonella F; Maione F; Pisacane A; David E; Torchio B; Risio M; Salizzoni M; Capussotti L; Perera T; Medico E; Di Renzo MF; Comoglio PM; Trusolino L; Bertotti A
    Clin Cancer Res; 2011 May; 17(10):3146-56. PubMed ID: 21447729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.
    de Jong MC; Nathan H; Sotiropoulos GC; Paul A; Alexandrescu S; Marques H; Pulitano C; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Bauer TW; Walters DM; Gamblin TC; Nguyen KT; Turley R; Popescu I; Hubert C; Meyer S; Schulick RD; Choti MA; Gigot JF; Mentha G; Pawlik TM
    J Clin Oncol; 2011 Aug; 29(23):3140-5. PubMed ID: 21730269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surgical therapy of proximal extrahepatic bile duct tumors (Klatskin tumors)].
    Timm S; Gassel HJ; Thiede A
    Zentralbl Chir; 2007 Aug; 132(4):328-35. PubMed ID: 17724636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
    Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
    Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis.
    Jin Z; Xu N; Guo K; Xu P; Li P; Zhang Y; Li X; Zheng S; Liu C; Xu A; Huang P
    Int J Clin Exp Pathol; 2015; 8(4):3857-63. PubMed ID: 26097569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma.
    Qu JH; Chang XJ; Lu YY; Bai WL; Chen Y; Zhou L; Zeng Z; Wang CP; An LJ; Hao LY; Xu GL; Gao XD; Lou M; Lv JY; Yang YP
    World J Gastroenterol; 2012 Jun; 18(23):2995-3003. PubMed ID: 22736924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.